Open AccessAntipsychotic prescription and polypharmacy among outpatients with schizophrenia in a Nigerian hospital
Author(s) -
IhechiluruGoodnews Anozie,
BawoO James,
JoyceO Omoaregba
Publication year - 2020
Publication title -
nigerian postgraduate medical journal
Language(s) - English
Resource type - Journals
ISSN - 1117-1936
DOI - 10.4103/npmj.npmj_93_19
Subject(s) - polypharmacy , antipsychotic , medicine , psychiatry , schizophrenia (object oriented programming) , medical prescription , anticholinergic , pharmacotherapy , pharmacology
International guidelines recommend antipsychotic monotherapy as the ideal treatment option in pharmacotherapy for schizophrenia, though this yields modest outcomes in a third of patients. Antipsychotic polypharmacy (APP) has been tried in many patients with schizophrenia to improve outcomes in those with poor treatment response.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom